5-Bromo-2-methoxy-4-methyl-3-nitropyridine | CAS:884495-14-1

We serve 5-Bromo-2-methoxy-4-methyl-3-nitropyridine CAS:884495-14-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Bromo-2-methoxy-4-methyl-3-nitropyridine

Chemical Name:5-Bromo-2-methoxy-4-methyl-3-nitropyridine
CAS.NO:884495-14-1
Synonyms:5-bromo-4-methyl-2-(methyloxy)-3-nitropyridine; 
5-bromo-2-methoxy-3-nitro-4-picoline;
Molecular Formula:C7H7BrN2O3
Molecular Weight:247.04600
 
Physical and Chemical Properties:
Density:1.636;
Melting point:87-89oC;
Boiling point:302.8oC;
Flash point:136.9oC;
Index of Refraction:1.577;
 
Specification:
Appearance:Light gold crystalline powder
Purity(GC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 



Contact us for information like 5-Bromo-2-methoxy-4-methyl-3-nitropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-2-methoxy-3-nitro-4-picoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Bromo-2-methoxy-4-methyl-3-nitropyridine Use and application,5-bromo-4-methyl-2-(methyloxy)-3-nitropyridine technical grade,usp/ep/jp grade.


Related News: When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.3-Bromo-2-chloro-5-methylpyridine manufacturer Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.4-Bromo-2,6-diphenylpyrimidine supplier In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.1,3-Diaminobenzene Sulfate vendor The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.“Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.